A Randomized Phase II Study: CRS207/GVAX plus Anti-PD-1 and Anti-CTLA4 Recruits Mesothelin- and mKRAS-Specific T Cells into PDAC.
一项随机 II 期研究:CRS207/GVAX 联合抗 PD-1 和抗 CTLA4 可将间皮素和 mKRAS 特异性 T 细胞募集到 PDAC 中。
期刊:Cancer Immunology Research
影响因子:8.2
doi:10.1158/2326-6066.CIR-25-0545
Bever Katherine M, Huff Amanda L, Danilova Ludmila, Wetzel Meredith, Tandurella Joseph A, Durham Jennifer N, Wang Tingchang, Lee Jae W, Coyne Erin M, Montagne Janelle M, Mitchell Jacob T, Hernandez Alexei G, Shin Sarah M, Anders Robert A, Wang Hao, Fertig Elana J, Jaffee Elizabeth M, Le Dung T, Ho Won Jin